Search
Results for 'imaging'
Clear-
Keeping Your Brain Healthy, No Matter Your Age
It’s true there is no cure for dementia, yet studies suggest your life choices today can reduce brain decline in the future. How important is diet to brain health? Food is the foundation of your body. Fats, carbs and protein provide the energy for your cells and metabolism. So the quality and amount of food you eat directly affects your brain. Specifically, researchers are paying special attention to the link a high sugar diet and/ or an unhealthy fat diet may have on your brain. Your brain on sugar According to the Alzheimer’s Association, when too much sugar is in the bloodstream for long periods of time, it can damage the brain cells. Many people with diabetes may develop brain abnormalities, and these changes may increase chances of dementia — research is still being done to understand this connection. Many U.S. adults have prediabetes with blood sugar higher than normal. Insulin resistance often leads to diabetes. Insulin resistance has been linked to metabolic syndrome, which is a precursor for cardiovascular and cerebrovascular disease (heart attack, stroke). Some signs of metabolic syndrome include: Large waist size (40 inches or more for men, 35 inches and up for women) Low HDL (good) cholesterol level Higher than normal blood pressure — 130/85 and above Current research suggests too much sugar in the blood causes inflammation, which can damage brain cells. High carbohydrate foods, such as sweetened beverages, chips, white rice, white potatoes, bagels, cereals and desserts, have been shown to raise blood sugar. Although anyone can get diabetes, Hispanic Americans and African Americans are at greater risk.
Read More About Keeping Your Brain Healthy, No Matter Your Age
-
Lung Cancer Screening and Early Detection
Lung cancer is the leading cause of cancer deaths in both men and women in the U.S. The good news is the five-year survival rate increases dramatically if lung cancer is treated before spreading to other parts of the body. Julie Locken, MD, of Renown Health Imaging, explains more. What are the signs and symptoms of lung cancer? As you might expect, most lung cancer symptoms appear in the chest and can affect your breathing. Watch for signs such as: Persistent cough Constant chest pain Shortness of breath Wheezing Bloody or rust-colored phlegm Hoarseness Swelling of the neck Pain or weakness in the shoulder, arm or hand Recurring pneumonia, bronchitis or other lung infections Loss of appetite and loss of weight can also be signs of lung cancer That said, there are usually no symptoms in the early stages of lung cancer, which means getting screened can truly be a lifesaver. If you have a history of smoking, you should get screened as a precaution. What are the risk factors of lung cancer? Around 80% of lung cancer cases stem from a history of smoking tobacco. But there are other known causes, such as secondhand smoke, radon, asbestos and diesel exhaust. It’s important to do what you can to eliminate exposure to all of these to reduce your lung cancer risk. People with an immediate relative – a parent, sibling or child – diagnosed with lung cancer and people between 50 and 80 years old are also at higher risk and may need to consider screening. People who are at the highest risk are those with a history of smoking tobacco, particularly smokers who averaged one pack of cigarettes per day for 20 years or more, as well as former heavy smokers who quit in the last 15 years.
-
Dr. Susan Lee to Lead Renown South Meadows Medical Center
Renown Health is pleased to announce that Susan Lee, DO, MBA will serve as Chief Operating Officer for Renown South Meadows Medical Center. Dr. Lee begins her new role on March 7, and succeeds Chris Nicholas, who resigned last month for a position with a health system in Florida. Tony Slonim, MD, DrPH, President & CEO, Renown Health, announced Dr. Lee’s internal promotion today by writing, “Embracing our vision to improve the health of our community, we are empowering leaders to play a greater role in improving physician, employee and patient experiences; growing services to our community; providing Reliable and Exact Care and meeting rigorous standards for operational excellence and efficiency.” Dr. Slonim noted that he was excited as, “Dr. Lee expands her role, promotes a spirit of unity across the enterprise, and continues to make progress on achieving goals central to Renown’s success.” In her new role as Chief Operating Officer for Renown South Meadows Medical Center, Dr. Lee will work with Jennifer Allen, MSN, director of nursing and the South Meadows leadership medical staff and team to lead South Meadows to achieve its strategic and operational goals. Dr. Lee is an experienced, dynamic physician executive and operational leader with a record of service growth, clinical quality, patient communication and execution. She is experienced in cross-functional collaboration and nationally recognized for organizational change management. Board certified in Internal Medicine and Psychiatry, Dr. Lee has based her clinical practice as a hospitalist on the mind-body connection and a collaborative model with patients and families. Dr. Lee joined Renown Health as the Chair of Medical Specialties in the summer of 2020 to manage hospital-based physician practices. She was promoted to Chief Medical Officer for Renown Regional Medical Center in February 2021 to oversee inpatient clinical operations, including length of stay, hospital capacity, care management functionality, interdisciplinary rounds and Medical Staff services. Since September of 2021, as Chief Medical Officer for Renown Acute Care, she has been responsible for clinical operations, strategic direction, hospital-based physician management, the Medical Staff Office, regulatory standards, and quality and financial outcomes for Renown Regional Medical Center, Renown South Meadows Medical Center and Renown Rehabilitation Hospital. Prior to serving at Renown, Dr. Lee served as Chief of Hospital Medicine at Carilion Clinic, a 7-facility nonprofit, integrated health system headquartered in Roanoke, Virginia. Dr. Lee is a graduate of the University of Massachusetts Amherst (MBA), Nova Southeastern University College of Osteopathic Medicine (DO) and Duke University (BA). She is an active member of the American College of Healthcare Executives and the American Association for Physician Leadership. Renown South Meadows Medical Center, located in south Reno, is a 76-bed acute care community hospital offering exceptional surgical and medical services in a nurturing environment. Renown South Meadows Medical Center is home to south Reno’s only 24/7 Emergency Department and staffed with Board-Certified Emergency physicians. Renown South Meadows Medical Center offers advanced care for patients including comprehensive primary care; x-ray and imaging services; lab services; heart care; OB/GYN; physical rehabilitation and pulmonary rehabilitation services; nuclear medicine and surgical services including orthopedics. As a not-for-profit organization, the Renown South Meadows Medical Center team embraces their role in improving the health and well-being of the people and communities served and provides necessary healthcare services regardless of race, creed, sex, national origin, handicap, age or ability to pay. In addition, Renown South Meadows Medical Center has been nationally recognized for providing the highest quality care and service, including: In U.S. News and World Report Best Hospital rankings, Renown South Meadows was listed #1 in the State of Nevada (tied with Carson Tahoe Medical Center) for 2020. Renown South Meadows was rated High Performing for Hip Replacement and Knee Replacement and COPD. A hospital's score is based on multiple data categories, including patient outcomes, safety and volumes. Hospitals earning a High Performing rating were significantly better than the national average. Renown South Meadows Medical Center received The Joint Commission’s Gold Seal of Approval® accreditation for Total Knee Replacement, Total Hip Replacement and Total Shoulder Replacement and was recognized as Top Performer on Key Quality Measures.® Dr. Lee says she "understands that health care today is as much about social skills and navigating multiple relationships as it is about clinical knowledge." Throughout her career, Dr. Lee has done much to contribute to a culture of innovation and transformation. Dr. Lee believes that, “providers need physicians, nurses and care teams who have high adaptability, flexibility, and, above all, the ability to care and be kind." Dr. Lee coaches teams to be responsive, empathic, have situational awareness and employ their clinical abilities at the highest level. She will often ask questions of her team to understand how they are "wired" to drive innovation and transformation- and to build culture and teamwork. She has hired and coached over 100 hospitalist physicians — many of them women — and promoted and served as a reference for hundreds of nurses, staff leader and advanced care providers. Dr. Lee serves as a peer mentor for other women, and men, who aspire to physician and healthcare leadership. The team at Renown South Meadows Medical Center is seeking great employees for careers in service; apply on line at https://careers.renown.org/.
Read More About Dr. Susan Lee to Lead Renown South Meadows Medical Center
-
William 'Bill' Plauth, MD, MMM, CPE Appointed Chief Medical Officer for Renown Health
Today, Renown Health announced the appointment of William “Bill” Plauth, MD, MMM, CPE as Chief Medical Officer for Renown Health, effective April 3, 2023. “I am excited to have Dr. Plauth join our team," said Brian Erling, MD, MBA, President & CEO of Renown Health. “Dr. Plauth is a distinguished physician with over 30 years of experience. Dr. Plauth’s extensive commitment to service is in alignment with our mission, vision, and values. He is a goal-oriented, collaborative executive who brings a depth of experience to Renown Health and to our community. He inspires others with his intelligence and proven abilities to engage others in advancing clinical quality and performance. I look forward to the strides our health system will make in helping people live better and healthier lives under his leadership.” In his role as Chief Medical Officer (CMO), Dr. Plauth will be responsible for continuous quality improvement, effective clinical resource management and serve as a liaison for organized medical staff activities. He will partner with nursing leadership to actively support performance improvement, risk management, and efficient resource utilization linked to evidence-based medicine. He will listen and foster a close relationship between and among physicians, management, and clinical staff. As CMO, Dr. Plauth will provide expertise, coordination, and leadership in support of elected medical staff leaders and partner with UNR Med leadership to ensure a positive training environment across Renown Health. “As a physician, I have always been humbled by the trust our patients and their families invest in all of us as a healthcare team,” says Bill Plauth, MD. “Over the years, to fulfill that trust, I have enjoyed engaging with my colleagues across clinical teams to adopt innovative approaches that respect those who do the work and to promote ease of practice. Such collaboration makes it possible for us to provide top-notch, compassionate care that addresses our patients' unique challenges and to improve their health and quality of life. At the end of the day, it is the people that make the difference.” Dr. Plauth adds, “I am delighted to join Renown Health, which as a not-for-profit, charitable health care organization has a long history of compassionate service. I look forward to working with my new medical, nursing, and administrative colleagues as we fulfill our mission of making a genuine difference in the health and wellbeing of the people and communities we serve.” Renown Health has more than 7,200 employees and serves Northern Nevada, Lake Tahoe, and Northeast California. The system includes Renown Regional Medical Center, Renown South Meadows Medical Center, Renown Rehabilitation Hospital and Renown Children’s Hospital. Renown also has over 50 medical group, urgent care, and outpatient imaging practices. Hometown Health is the insurance division of Renown Health and is northern Nevada’s largest local, not-for- profit health insurance company that provides wide-ranging medical coverage. Since 2014, Dr. Plauth has provided clinical leadership at Centura Health (CO), first serving as Chief Medical Officer at Mercy Regional Medical Center in Durango, CO, and then for the last four years as Chief Medical Officer for Centura Penrose & St. Francis Hospitals in Colorado Springs. He was responsible for clinical quality, high reliability patient safety initiatives, process improvement, pharmacy, care management, infection control and medical staff services. Formerly, Dr. Plauth served for fourteen years with CHRISTUS St. Vincent Regional Medical Center in Santa Fe, NM, first as a hospitalist and then with concurrent roles that included Chief of Staff; Medical Director, Clinical Informatics; Medical Director, Palliative Care and Acting Chief Medical Officer for Quality and Medical Staff Affairs. Board certified in both Internal Medicine and Hospice & Palliative Care, Dr. Plauth is a leader in quality improvement, patient safety and clinical informatics. He has also served as a medical director of a Long-Term Care and Skilled Nursing Center. Dr. Plauth received his Bachelor of Arts in Economics from the University of Virginia, Charlottesville, and his Medical Doctorate from Emory University in Atlanta with a sub-internship at Brigham and Women’s Hospital in Boston. He completed his internship and residency at University of California San Francisco, where he also served as Chief Resident. In the most recent U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 in the State of Nevada. No other hospital in Nevada earned recognition from U.S. News. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit www.renown.org/careers.
-
Renown Health Announces Cancer Program Leadership Team
Dr. Max J. Coppes announced as Cancer Center Directory, Larry Duncan as Cancer Center Administrator for Renown's Institute for Cancer, with goal to improve the health and well-being of Nevadans. Renown Health is excited to announce that effective today, Max J. Coppes, MD, PhD, MBA has been appointed to a new leadership role as the Cancer Center Director for Renown’s Institute for Cancer. Dr. Coppes, a pediatric oncologist by training, has experience in leading large-scale, nationally-recognized academic adult and pediatric cancer center teams in both the U.S. and Canada. “If you know Dr. Coppes, you know he has the passion, dedication and commitment to build and foster the partnerships needed to create a leading comprehensive cancer center and program that spans the spectrum for patients and their families; from prevention to treatment to survivorship to palliative care,” said Tony Slonim, MD, DrPH, President and CEO, Renown Health. Also effective today, Larry Duncan, MS, has been appointed as Cancer Center Administrator for Renown Health, working in dyad partnership with Dr. Coppes to support the development of this important service line. Larry will also continue his service as Vice President of Pediatrics and Surgery & Administrator of Renown Children's & Women’s Services “Together, as they have done so successfully for Renown Children’s Hospital, Dr. Coppes and Larry Duncan will be responsible for the strategic direction, operations, fiscal management and recruitment of professionals to the Renown Institute for Cancer,” said Sy Johnson, MBA, chief of staff for Renown Health. “As one of Renown’s ‘Destination Health’ service lines, Dr. Coppes and Larry will continue to support an integrated leadership model that puts the patient at the center of all that we do.” Dr. Coppes came to Reno in 2014 from the British Columbia Cancer Agency in Vancouver, where he served as president with responsibility for six regional cancer centers and two cancer research centers. He was an attending physician at BC Children's Hospital, an adjunct professor of Health Sciences at Simon Fraser University, and a professor of Medicine and Pediatrics at the University of British Columbia. During his career, Coppes served as senior vice president at Children's National Medical Center in Washington, D.C. and held positions at several prestigious facilities in the U.S. and Canada including The Hospital for Sick Children (SickKids) in Toronto, Georgetown University, The National Cancer Institute, and the Cleveland Clinic. Since 2016, Dr. Coppes has served in the joint leadership role as the Nell J. Redfield Chair of Pediatrics at the University of Nevada School of Medicine and pediatrician-in-chief at Renown Children's Hospital, a position made possible through generous philanthropic support from the Nell J. Redfield Foundation along with investments by Renown Health and the UNR School of Medicine. Over the last five years, Duncan has served as Vice President of Pediatrics and Surgery & Administrator of Renown Children's and Women's Hospital, with oversight for Renown’s Pediatric Emergency Room and general and specialty pediatric physician practices. He has also served as Chief Operating Officer for Renown Regional Medical Center with oversight of pharmacy, imaging, nutrition, laboratory services and operating rooms. Prior to coming to Renown, Duncan served as CEO for El Paso Children’s Hospital and served in executive capacities for Children's Hospital of Wisconsin, The Children's Hospital of Philadelphia and Rush University Medical Center. “The Renown Institute for Cancer has Full Accreditation with Commendation from the Commission on Cancer of the American College of Surgeons in all 7 areas. Only 25% of cancer programs attain this distinction, which recognizes the quality of comprehensive, multidisciplinary patient care. Renown is the only accredited Community Hospital Comprehensive Cancer program in northern Nevada to be selected, and one of only three programs statewide,” says Max J. Coppes, MD, PhD, MBA. “That is certainly an excellent foundation on which to build on, and such a gift for our community.” “Renown’s cancer nurses, patient navigators, social workers, palliative care specialists, geneticists, nutritionists, clinical trial researchers, physical rehab specialists and the entire team provides prevention and screening to help reduce the incidence of cancer and reduce the late stage presentation of cancers,” says Larry Duncan, MS. “Helping patients and families navigate their journey begins at the time of diagnosis, with the help of our nurse navigators, and extends throughout the patient’s treatment. We are making great strides in long-term survivorship and are pleased to be recognized for the comprehensive nature of our research, care, education and community outreach programs.” According to the National Cancer Institute, the Age-Adjusted Death Rate of 153.5 per 100,000 population due to Cancer for Washoe County has seen significant improvement in the last several years, and now meets the Healthy People 2020 national health target of reducing the overall cancer death rate below 161.4 per 100,000 population. The Healthy People 2030 national health target is to reduce the overall cancer death rate to 122.7 deaths per 100,000 population. The National Cancer Institute (NCI) defines cancer as a term used to describe diseases in which abnormal cells divide without control and are able to invade other tissues. According to the NCI there are over 100 different types of cancer, but breast, colon, lung, pancreatic, prostate, and rectal cancer lead to the greatest number of annual deaths. Risk factors of cancer include but are not limited to; age, alcohol use, tobacco use, a poor diet, certain hormones, and sun exposure. Although some of these risk factors cannot be avoided -- such as age -- limiting exposure to avoidable risk factors may lower risk of developing certain cancers. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project® . For more information visit, www.renown.
Read More About Renown Health Announces Cancer Program Leadership Team
-
Renown Institute Expands Partnership to Offer ELF Testing
Together, will test over 30,000 qualifying study participants by 2023 for risk of cirrhosis and liver-related illnesses. Renown Institute for Health Innovation (IHI) announced today that the organization and Gilead Sciences, Inc. will be joining forces with Siemens Healthineers to offer the Enhanced Liver Fibrosis (ELF™) Test to people with risks for nonalcoholic steatohepatitis (NASH) enrolled in the Healthy Nevada Project (HNP). The ELF Test will help identify people most at risk for progressing to cirrhosis and liver-related outcomes and allow healthcare providers to intervene before irreparable damage occurs. This noninvasive blood test uses three serum biomarkers to create an ELF score from a predefined algorithm, which can be used by doctors to help evaluate if a patient requires increased medical care and monitoring for their condition. Nonalcoholic fatty liver disease (NAFLD), which includes NASH, is prevalent in Nevada and under-diagnosed, likely affecting more than 500,000 adult Nevadans. If undetected and untreated, NASH can result in liver cirrhosis and may require liver transplantation or lead to death. There are more than 12,000 people on a waitlist for liver transplantation in the U.S. and this number continues to rise due to the increasing prevalence of NAFLD. “Thanks to important data collected through our Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study, we now know that NASH is prevalent in the state of Nevada,” said Tony Slonim, M.D., DrPH, FACHE, president and CEO of Renown Health. “We are proud to expand our partnership with Gilead and begin working with Siemens Healthineers to improve health of those with liver disease and to take early detection one step further by offering Enhanced Liver Fibrosis, ELF testing for patients of Renown Health. This test provides our team of highly-skilled physicians an advanced, noninvasive method to actively assess dynamic liver fibrosis in study participants and intervene whenever necessary, contributing to a healthier Nevada.” “Gilead believes that noninvasive tests, including the ELF Test, will help improve the experience of people living with NASH. These tests may help to diagnose liver disease, monitor disease progression and evaluate responses to treatment without the requirement for liver biopsy,” said Rob Myers, MD, Vice President, Liver Fibrosis Clinical Research at Gilead Sciences. “The ELF Test has proven itself to be a valuable tool in NASH management and we hope this partnership will further support its use in routine care.” “We are very pleased that NASH patients in the Healthy Nevada Project now have access to the ELF Test which offers clinically useful prognostic information for their condition with the convenience of a simple blood test. Using our advanced laboratory expertise together with Renown IHI and Gilead, we can work towards better understanding of NASH and liver disease in a representative patient population,” said Sebastian Kronmueller, Head of Molecular Diagnostics at Siemens Healthineers. “We launched the Healthy Nevada Project to help people understand more about their health, to identify serious health risks, and to give people access to innovations like the ELF Test, so they can live their best lives,” said Renown’s chief scientific officer, Dr. Joseph Grzymski, who is also a research professor at the Desert Research Institute and principal investigator of the Healthy Nevada Project. It’s incredibly rewarding to be able to report clinical findings to help our 50,000 volunteer study participants, and to assist healthcare providers in helping their patients.” The provision of the ELF Test builds on a previously announced strategic collaboration between the Renown IHI and Gilead in July 2019. This ongoing partnership aims to collect and analyze de-identified genetic and electronic health data from 60,000 qualifying study participants to enhance the understanding of NAFLD and NASH and to potentially inform development of treatment options for these diseases. About NAFLD and NASH NAFLD is a build-up of fat in the liver of people who do not have a history of alcohol misuse. It is normal for the liver to contain some fat, but if more than 5 percent of the liver content is fat, it’s considered a fatty liver (steatosis). NASH is the most severe form of NAFLD in which a person has liver cell damage and inflammation of the liver. Inflammation and liver cell damage can cause fibrosis, or scarring of the liver, and can cause decreased liver function (1). The symptoms of NASH are often silent or non-specific, making it difficult to diagnose. About one-third of people with NASH develop cirrhosis or irreversible liver damage (2). About the ELF™ Test The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. For more information or to enroll, please contact RenownIHI@renown.org or (775) 982-6914. The Enhanced Liver Fibrosis (ELF™) Test kit is not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements. In the U.S., the ELF Testing Service is available from Siemens Healthcare Laboratory, LLC (SHL), a CLIA-certified laboratory located in Berkeley, Calif. The ELF Testing Service, including the establishment of performance characteristics, was developed by SHL. The ELF Test has not been cleared or approved by the U.S. Food and Drug Administration. SHL is regulated under CLIA as qualified to perform high complexity testing. The ELF Test is used for clinical purposes and should not be regarded as investigational use only or research use only. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Health, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information visit, renown.org. About the Renown Institute for Health Innovation Renown Institute for Health Innovation is a collaboration between Renown Health - a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute - a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at healthynv.org. Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has over 60,000 participants. For more information, visit healthynv.org. About Siemens Healthineers Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Further information is available at www.siemens-healthineers.com.Media Contact for Siemens Healthineers: Lance LongwellM: 610-448-6341E: lance.longwell@siemens-healthineers.com
Read More About Renown Institute Expands Partnership to Offer ELF Testing
-
Department Spotlight Clinical Research
May 20 is National Clinical Trials Day. Celebrate with us by recognizing the Clinical Research team at Renown Health! The root of every medication, treatment and procedure in healthcare can be traced back to research. From the beginning of the history of medicine, research has always played a crucial role in improving the lives of patients around the world, leaving a permanent mark on how we expand our medical capabilities to this day. Renown Health’s Clinical Research team, in partnership with the University of Nevada, Reno School of Medicine (UNR Med), are leading that effort in our very own community. As our in-house leaders of clinical trials, this team is dedicated to advancing the science of medicine to help further our bottom line of making a genuine difference in the health and well-being of the patients they serve. Trial by (Medical) Jury Every day looks different for the Clinical Research team, especially when it comes to interacting with patients, providers and “sponsors,” which are the organizations providing the treatment for the study. One fact always remains true: communication and collaboration are key, especially among the team who act as the face of this process. Meet Lisa English (pictured above on the far right in a blue shirt), a Lead Clinical Research Coordinator at Renown who serves as the study "project manager." One aspect of Lisa’s day-to-day is seeing patients through their clinical trials from start to finish. It all begins with the setup. “Before we can launch a study, there is a lot of back-and-forth dialogue between everyone involved to ensure the best fit,” said Lisa. “Sponsors will come to us with novel treatments, such as medications or devices, and the inclusion criteria that patients need to meet in order to qualify for the study. We then immediately jump into working with the providers, looking closely at the science and comparing the treatments to what is on the market already.” From there, Lisa coordinates conversations between the providers, sponsors and study teams to gauge everyone’s capacity based on the length of the study, ensuring everyone involved has the time to dedicate to the process. Next, the providers identify patients that meet the criteria for the study, and together, the team decides where the patient visits will happen and discusses any potential barriers that may affect patient retention. The budget is clearly defined at this stage, set up to make sure no patient is ever billed for medical costs incurred as a result of the study. Often, research participants are seen within the specialty clinics throughout the health system, while other times the Clinical Research Coordinators see patients at the recently centralized Clinical Research Office at Renown Regional Medical Center. This location provides an essential public-facing space for the community to learn more about clinical trials and demonstrates the breadth of resources available at Renown to sponsors to strengthen external partnerships and research funding opportunities. Once the study officially begins, team members like Lisa will set patients up for a “screening/qualifying visit.” During this appointment, she makes sure patients get scheduled for their lab work, imaging scans and anything else the provider may need to make an executive decision on whether or not the patient is a good candidate for the study. “I build it all in Epic,” said Lisa. “The study information, directions, requirements and next steps are all loaded in Epic for easy tracking. We are also required to input any notes in the sponsor’s electronic data capture website. All the information I track is inputted without protected health information (PHI), so every patient is completely anonymous.” After the patient officially qualifies, the study goes full steam ahead. Team members like Lisa and the providers receive continual updates from sponsors on the status of the study. “Throughout the entire process, I make sure patients get scheduled for everything that meets the requirements for the study,” said Lisa. “I meet with patients one-on-one to discuss their needs and concerns and ask questions about the study, organize their appointments and charts and deal with any issues or pivots that may arise. It’s very important that every patient fully understands what is going to happen with their care.” The Clinical Research department strives to serve as a care partner to patients, providers and clinics they work with. The majority of our Clinical Research Coordinators are trained phlebotomists and medical assistants, performing their own assessments such as lab draws and electrocardiograms (ECGs) to streamline the research visit process and reduce resource constraints on the clinics and health system. Lisa typically sees a couple of patients per week, depending on the study and where patients are in the cycle. Depending on the complexity of the trial, patients may see the research team only one time or several times over many years. Typically, clinical trial patients are seen in clinic every 2-4 weeks. There are many tasks required before, during and after a research visit to ensure everything runs smoothly, so Clinical Research Coordinators dedicate an average of 5-11 hours of work per patient, per visit. Regardless of patient load, each employee in the Clinical Research department – as well as participating teams across Renown and UNR Med – always step in to help each other out. According to Lisa, the environment is immensely supportive. “We have a program here at Renown to train employees who have never done clinical trials,” said Lisa. “We love seeing people get more engaged with the important work we do, and every department has been great at collaborating with us. Everyone brings a different perspective.” At the end of the study, Lisa gathers all the information and collects notes into a zip drive or paper binder for archiving. The sponsor lets the Clinical Research team, providers and patients know whether they are on the trial drug or on the placebo. The teams use the data gathered during the study to publish a report or present at conferences, promoting the critical research done to better the lives of patients in our community, and potentially, the world. “I appreciate the time everyone gives us to make sure our research is successful,” said Lisa. “It feels great to work together to make a difference, improve healthcare quality and save lives.” Behind-the-Scenes, Yet on the Frontlines The impact of research studies transcends hospital walls, and this can all be attributed to the dedication of our Clinical Research department. The constant collaboration between this team, lab science, medical assistants and providers, cardiology technologists, sonographers, finance teams and our partners at UNR Med is crucial to safeguarding the success of the studies. Devoted to keeping research close to home, Renown and UNR Med teamed up to form the Clinical Research Office (CRO) in 2021. With the strength of northern Nevada's largest not-for-profit health system and Nevada’s first medical school, this team is dedicated to giving our community access to the latest care innovations. “At UNR Med, we are working with students, residents and academic faculty; on the Renown side, we are working with clinicians and community participants,” said Amber Emerson, Manager for Community Outreach and Research Engagement for UNR Med. “Everything we do is data-driven,” added Kristen Gurnea, Manager of Clinical Research for Renown. “Our main goal is to optimize our impact and provide a community benefit for our patients. The scope of our roles in the Clinical Research office is very diverse.” To help meet the growing need locally for healthcare and cutting-edge treatment solutions, the CRO has continued to grow, expanding its research capabilities and helping bring new medications, medical devices and more to patients across northern Nevada and northeastern California. “Once upon a time, our team had only six members; today we have grown to a team of 25,” added Diana Torres, Research Resource Analyst for Renown. “We used to be considered one department, including Medical Education, and we have since branched off into our own cost center. We branched off even further and created a separate Genetics department that runs the Healthy Nevada Project. Throughout this process, the Clinical Research department was always the main point of the umbrella.” “We participate in hospital-wide outreach and marketing, and we feel this has really helped us get the word out about our department,” added Raul Arellano, Research Resource Analyst for Renown. “In fact, we doubled our clinical trial portfolio from last year.” The CRO currently operates over 100 clinical trials locally in cardiology, endocrinology, infectious disease, neurology, pediatric and adult oncology, pediatric sub-specialties and pulmonology. Behind the curtains of in-person research, the CRO is home to several experts who help turn our research studies into a reality, from budgeting and billing to barrier-breaking and building relationships. “I help with barriers patients and Clinical Research Coordinators are facing, building connections and relationships inside and outside of our health system,” said Kristen Gurnea. “I enjoy handling all the supporting pieces that are required for studies to happen.” “My role changes every day,” added Jenna Berger, Administrative Assistant for the CRO at Renown. “Some days, I’ll be helping coordinate patient stipends and going through document management to ensure we have all necessary signatures. Other days, I will be planning events – like Clinical Trials Week – for our department and creating marketing materials and fliers.” “Our day-to-day involves going over anything related to research financials,” added Diana Torres. “We handle sponsor billings, process efficiency and collecting revenue for research contracts, and we collaborate closely with our Finance department and Revenue Integrity in order to accomplish this. It’s important for us to make sure all billing on both the sponsor and patient side is taken care of, especially because patients should never receive a bill for medical services they receive for the trial. A year and a half ago, we started doing budget negotiations for research contracts,” said Diana Torres. “We are proud to help clinical teams with any training they may need on these negotiations as well as billing reviews and allocations.” Seeing patients progress during a study and transform before their eyes inspires the CRO team to continue doing what they do every day. “I’ve been here for many years, first working on the floor as an oncology nurse and transitioning to oncology research in 2005,” said Anna Winchell, Cancer Protocol Nurse for Renown. “I love getting to know the patients and seeing them progress into a healthy lifestyle.” Medical students and residents at UNR Med also play a significant role in the research process, advancing medicine by exploring causes and novel treatments for a wide range of conditions, including HIV, muscular dystrophy, gastrointestinal disorders, infectious diseases and more. Medical research at UNR Med is headed by committed research coordinators, community outreach managers, grants managers, pharmacists and physicians. “I oversee scientific review and help the physicians that come to us for those resources,” said Amil Trujillo-King, Medical Research Coordinator at UNR Med. “I guide medical students in their research protocols and help with different projects to improve research activities for both students and medical residents.” It takes a village to make clinical research happen. Because of that, the ACRO cannot thank the following teams enough for moving mountains for the future of medicine: Renown Health and UNR Med leadership for demonstrating the integrated health system’s commitment to expanding access to clinical research in our community within both the Renown / UNR Med affiliation and Renown active strategic plans. Renown Pharmacy especially Research Clinical Pharmacist Tim Morton, who supports all clinical trial medication dispensing and patient education across all clinical trials at Renown. Accounts Payable for having a huge impact on patient and employee reimbursement. Renown Medical Group for their participating providers, especially in oncology, cardiology, pulmonology, pediatrics, endocrinology and neurology, who are involved in research year after year. Marketing and Communications for helping with printed materials and raising awareness for clinical research at Renown and UNR Med. An Affiliation to Last Through the Ages A collective, shared vision of exploring community health – that is the impetus behind the affiliation between Renown and UNR Med. By leveraging resources across both institutions, the CRO has maximized their impact, giving the people of northern Nevada greater access to new interventions and treatments and promoting an impassioned culture with patients, providers, residents and medical students. “Community-based research always sat well with me,” said Amber Emerson. “As Renown and UNR Med, we have this unique opportunity to shape clinical research here in northern Nevada. We always make sure we present research in a meaningful way that speaks to the work we produce and demonstrates the opportunities we offer. After all, participating in clinical research doesn’t mean our patients are ‘guinea pigs’ – quite the opposite! They are partners in their health care, and we support them through providing access to novel treatments.” “Research is my passion, and my career has spanned broadly from grants administration to study coordination,” added Valerie Smith, Clinical Research Center Administrative Manager at UNR Med. “I am excited to be at the forefront of research frontiers in northern Nevada.” Through robust engagement and collaboration with healthcare providers, department administrators, internal research team members and leadership, the strength of this affiliation is unmeasurable. The CRO’s ultimate goal is to have clinical trials be the standard of care for every condition that Renown and UNR Med treats. Clinical research participation is all about patient autonomy, shared decision-making between patients and their providers and advancing medicine to save lives. From their beginnings as a small group of passionate researchers to their present reality as a leader in the research space in northern Nevada, their efforts do not go unnoticed. “The success of our department is inspiring,” said Amil Trujillo-King. “Renown and UNR Med supports the wellbeing of all employees and contributes directly to the growth of the department.” “When I first joined Renown in Patient Access, I didn’t realize that we had a research department; with a strong healthcare background in my family, I knew I wanted to grow in my career, and our expanding Clinical Research office was that next step,” said Raul Arellano. “With our affiliation with UNR Med, it’s especially inspiring to be able to apply what I learned as a Patient Access Representative to help further outcomes for our patients through managing our finances.” Through their unwavering commitment to research excellence and patient-centered care, the CRO will continue to pave the way for groundbreaking medical discoveries and improved outcomes for patients for years to come. “Fundamentally, we’re working to build a culture of research in our community because we believe it is the right thing to do. Our community deserves to have access to clinical trials and novel care close to home with a dedicated team to support them every step of the way,” closes Kristen Gurnea.
-
-
22May
Would you please join us for Renown Health’s free one-hour virtual class for Chronic Obstructive Pulmonary Disease (COPD) education? Our goal is to give you the knowledge to better manage your COPD by increasing your understanding of the disease process, medications and how to use them and creating an action plan you can use every day. This program is offered on the 4th Wednesday of each month and will meet from 3 to 4 p.m. Upon registering, you will receive instructions on virtually connecting 1 day before the class.
Read More About COPD Virtual Class
-
-
-
23Oct
Would you please join us for Renown Health’s free one-hour virtual class for Chronic Obstructive Pulmonary Disease (COPD) education? Our goal is to give you the knowledge to better manage your COPD by increasing your understanding of the disease process, medications and how to use them and creating an action plan you can use every day. This program is offered on the 4th Wednesday of each month and will meet from 3 to 4 p.m. Upon registering, you will receive instructions on virtually connecting 1 day before the class.
Read More About COPD Virtual Class
-
-
-
28Aug
Would you please join us for Renown Health’s free one-hour virtual class for Chronic Obstructive Pulmonary Disease (COPD) education? Our goal is to give you the knowledge to better manage your COPD by increasing your understanding of the disease process, medications and how to use them and creating an action plan you can use every day. This program is offered on the 4th Wednesday of each month and will meet from 3 to 4 p.m. Upon registering, you will receive instructions on virtually connecting 1 day before the class.
Read More About COPD Virtual Class
-
-
-
25Sep
Would you please join us for Renown Health’s free one-hour virtual class for Chronic Obstructive Pulmonary Disease (COPD) education? Our goal is to give you the knowledge to better manage your COPD by increasing your understanding of the disease process, medications and how to use them and creating an action plan you can use every day. This program is offered on the 4th Wednesday of each month and will meet from 3 to 4 p.m. Upon registering, you will receive instructions on virtually connecting 1 day before the class.
Read More About COPD Virtual Class
-
-
-
24Jul
Would you please join us for Renown Health’s free one-hour virtual class for Chronic Obstructive Pulmonary Disease (COPD) education? Our goal is to give you the knowledge to better manage your COPD by increasing your understanding of the disease process, medications and how to use them and creating an action plan you can use every day. This program is offered on the 4th Wednesday of each month and will meet from 3 to 4 p.m. Upon registering, you will receive instructions on virtually connecting 1 day before the class.
Read More About COPD Virtual Class
-